24.04.2015 • News

Total Spending €600 Million on Refinery Conversions

Total has revealed plans to revamp and upgrade two of its five refineries in France to meet the demands of new markets and restore profitability.

The oil and petrochemicals giant is spending €200 million to turn the La Mède facility in the south into France's first biorefinery. As one of the biggest in Europe, the upgraded plant will be able to meet the growing demand for biofuels, it says. Crude oil processing here will be phased out up to the end of 2016.

At Donges, near Nantes, Total will spend €400 million to convert its refinery to produce low-sulphur fuels in line with the latest EU specifications and to "capture profitable markets."

Conversion of the facilities will take place without layoffs or personnel transfers to other group sites, the group stressed.

CEO Patrick Pouyanné pointed to the need to realign refinery operations and products in Europe to the meet the needs of changing markets and react to a decline in profitability, which Total blames on overcapacity and heightened competition from players in Asia and the Middle East as well as US companies with access to cheap shale oil and gas.

Total said there is no need to convert the refineries at Gonfreville in Normandy, Grandpuits in the Paris region and Feyzin near Lyon, as these have state-of-the-art operations and are still profitable despite the deteriorating refinery climate.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.